Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share of Common Stock

v3.22.2
Net Loss per Share of Common Stock
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Net Loss per Share of Common Stock

Note 5 – Net Loss per Share of Common Stock

 

Net Loss Per Share

 

Basic net loss per share is computed by dividing our net loss available to common shareholders by the weighted average number of shares of common stock outstanding (which excludes unvested RSAs and includes vested RSUs) during the period. Diluted loss per share is computed by dividing our net loss available to common shareholders by the diluted weighted average number of shares of common stock (which includes the potentially dilutive effect of stock options, unvested RSAs, unvested RSUs and warrants) during the period. Since we experienced a net loss for both periods presented, basic and diluted net loss per share are the same. As such, diluted loss per share for the three and six month periods ended June 30, 2022 and 2021 excludes the impact of potentially dilutive common shares since those shares would have an anti-dilutive effect on net loss per share.

 

The computation of net loss per share for the three and six month periods ended June 30, 2022 and 2021 was as follows:

 

    2022     2021     2022     2021  
    Three Months Ended June 30,     Six Months Ended June 30,  
    2022     2021     2022     2021  
Basic and diluted net loss per share:                                
Net loss available to common stockholders   $ (5,164,368 )   $ (3,157,043 )   $ (8,391,499 )   $ (5,256,523 )
Weighted average number of common shares-basic and diluted     15,940,510       15,406,363       15,886,116       14,997,303  
                                 
Basic and diluted net loss per share   $ (0.32 )   $ (0.20 )   $ (0.53 )   $ (0.35 )

 

Our diluted net loss per share for the three and six month periods ended June 30, 2022 and 2021 excluded 1,965,502 and 709,954 of potentially dilutive common shares, respectively, related to outstanding stock options, stock purchase warrants and unvested restricted stock since those shares would have had an anti-dilutive effect on net loss per share during the periods then ended.